2m 2m 2m 2m 2m 2m 2m
ARCUS BIOSCIENS (RCUS)
NYSE
$28.17+$0.94 (+3.45%)
Price as of Jun 23, 2026 6:47 PM EDT- $3.4BMarket Cap
- 215.53%1-Year Change
- BiotechnologyIndustry
ARCUS BIOSCIENS (RCUS)
$28.17+$0.94 (+3.45%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 214.0M -17.05% | 258.0M +120.51% | 117.0M +4.46% | 112.0M -70.75% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 214.0M -17.05% | 258.0M +120.51% | 117.0M +4.46% | 112.0M -70.75% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -523.0M +16.74% | -448.0M +31.76% | -340.0M +18.06% | -288.0M +12.35% | |
Depreciation and Amortization Expense | 10.0M 0.00% | 10.0M +25.00% | 8.0M +33.33% | 6.0M +56.13% | |
Total Operating Expenses | 633.0M +7.65% | 588.0M +28.67% | 457.0M +16.58% | 392.0M +19.28% | |
Operating Profit | -386.0M +16.97% | -330.0M -2.94% | -340.0M +21.43% | -280.0M -616.15% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -9.0M +350.00% | -2.0M N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -9.0M +350.00% | -2.0M N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 33.0M -31.25% | 48.0M +23.08% | 39.0M +178.57% | 14.0M +3,426.45% | |
Income before Taxes | -353.0M +25.18% | -282.0M -6.31% | -301.0M +13.16% | -266.0M -586.78% | |
Income Taxes | 0 -100.00% | 1.0M -83.33% | 6.0M +500.00% | 1.0M -44.90% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -353.0M +24.73% | -283.0M -7.82% | -307.0M +14.98% | -267.0M -605.39% | |
Net Income from Continuing Operations Applicable to Common | -353.0M +25.18% | -282.0M -6.31% | -301.0M +13.16% | -266.0M -586.78% | |
Basic EPS and Net Income | -3.29 +4.78% | -3.14 -24.34% | -4.15 +11.86% | -3.71 -588.16% | |
Diluted EPS and Net Income | -3.29 +4.78% | -3.14 -24.34% | -4.15 +11.86% | -3.71 -622.54% | |
Basic Weighted Average Shares | 107.4M +19.20% | 90.1M +21.76% | 74.0M +2.78% | 72.0M +3.83% | |
Diluted Weighted Average Shares | 107.4M +19.20% | 90.1M +21.76% | 74.0M +2.78% | 72.0M -2.66% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 222.0M +48.00% | 150.0M +18.11% | 127.0M -38.35% | 206.0M +39.27% | |
Short-Term Investments | 759.0M -8.33% | 828.0M +31.01% | 632.0M -21.30% | 803.0M +128.52% | |
Cash and Cash Equivalents and Short-Term Investments | 981.0M +0.31% | 978.0M +28.85% | 759.0M -24.78% | 1.0B +102.08% | |
Total Current Assets | 1.0B -0.89% | 1.0B +22.26% | 831.0M -22.12% | 1.1B -15.43% | |
Accumulated Depreciation | 50.0M +21.95% | 41.0M +32.26% | 31.0M +34.78% | 23.0M +29.74% | |
Property and Plant and Equipment and Net | 40.0M -14.89% | 47.0M -7.84% | 51.0M +45.71% | 35.0M +7.84% | |
Total Long-Term Assets | 63.0M -13.70% | 73.0M -31.13% | 106.0M -7.02% | 114.0M +1,374.77% | |
Total Assets | 1.1B -0.96% | 1.1B +5.02% | 1.1B -18.59% | 1.3B -15.51% | |
Income Taxes Payable | 1.0M 0.00% | 1.0M N/A | N/A N/A | 2.0M +10.19% | |
Total Short-Term Debt | 3.0M 0.00% | 3.0M 0.00% | 3.0M 0.00% | 3.0M N/A | |
Total Current Liabilities | 231.0M +2.21% | 226.0M +22.83% | 184.0M -4.66% | 193.0M +16.21% | |
Total Long-Term Debt | 99.0M +106.25% | 48.0M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 135.0M -14.01% | 157.0M +10.56% | 142.0M +1.43% | 140.0M +2,561.60% | |
Total Liabilities | 231.0M +2.21% | 226.0M +22.83% | 184.0M -4.66% | 193.0M -74.28% | |
Retained Earnings | -1.5B +31.18% | -1.1B +33.33% | -849.0M +56.64% | -542.0M +96.84% | |
Total Stockholders Equity | 631.0M +30.10% | 485.0M +4.98% | 462.0M -29.68% | 657.0M -21.92% | |
Total Shares Outstanding | 125.3M +35.90% | 92.2M +22.12% | 75.5M +3.57% | 72.9M +2.99% | |
Cash Flow | |||||
Cash from Operating Activities | -482.0M +183.53% | -170.0M -44.44% | -306.0M -169.86% | 438.0M +270.98% | |
Capital Expenditures | 2.0M -66.67% | 6.0M -75.00% | 24.0M +300.00% | 6.0M -76.99% | |
Cash from Investing Activities | 66.0M +178.57% | -84.0M -143.30% | 194.0M +146.97% | -413.0M +10,577.35% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 488.0M +76.17% | 277.0M +739.39% | 33.0M 0.00% | 33.0M -86.10% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -180.37% +41.02% | -127.91% -55.98% | -290.60% +16.24% | -250.00% -1,864.50% | |
Return on Assets | -30.84% +22.34% | -25.21% +0.19% | -25.16% +38.40% | -18.18% -506.84% | |
Return on Equity | -63.26% +5.85% | -59.77% +8.93% | -54.87% +53.97% | -35.64% -553.22% | |
Revenue Growth | -17.05% -114.15% | 120.51% +2,599.48% | 4.46% +106.31% | -70.75% -117.96% | |
Current Ratio | 4.36 -3.03% | 4.50 -0.46% | 4.52 -18.31% | 5.53 -27.23% | |
Cash Ratio | 0.96 +44.79% | 0.66 -3.84% | 0.69 -35.34% | 1.07 +19.85% | |
Debt-to-Equity Ratio | 0.16 +53.61% | 0.11 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.09 +102.26% | 0.04 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow